Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Last updated on 2019-05-23 History
Report ID 13528
Drug Identification Number 02443449
Brand name MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Common or Proper name NAPROXEN/ESOMEPRAZOLE MR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE NAPROXEN
Strength(s) 20MG 500MG
Dosage form(s) TABLET (IMMEDIATE AND DELAYED-RELEASE)
Route of administration ORAL
Packaging size 60BT
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-05-15
Actual start date
Estimated end date 2019-05-22
Actual end date 2019-05-22
Shortage status Resolved
Updated date 2019-05-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v45 2018-10-10 English Compare
v44 2018-10-09 French Compare
v43 2018-10-09 English Compare
v42 2018-10-05 English Compare
v41 2018-10-03 French Compare
v40 2018-10-03 English Compare
v39 2018-10-01 French Compare
v38 2018-10-01 English Compare
v37 2018-09-25 English Compare
v36 2018-09-24 French Compare
v35 2018-09-24 English Compare
v34 2018-09-20 French Compare
v33 2018-09-20 English Compare
v32 2018-09-17 French Compare
v31 2018-09-17 English Compare
v30 2018-09-13 French Compare
v29 2018-09-13 English Compare
v28 2018-09-13 English Compare
v27 2018-07-26 English Compare
v26 2018-07-25 French Compare

Showing 41 to 60 of 85